Vaccine 1st puts spotlight on German pharma company BioNTech
Associated Press
1 / 4
File -- In this Tuesday, Nov.10, 2020 file photo windows are illuminated at the headquarters of the German biotechnology company BioNTech in Mainz, Germany. Pfizer and BioNTech say they've won permission Wednesday, Dec. 2, 2020, for emergency use of their COVID-19 vaccine in Britain, the world's first coronavirus shot that's backed by rigorous science -- and a major step toward eventually ending the pandemic.(AP Photo/Michael Probst, file)FILE - In this Nov. 9, 2020, file photo, an ad for COVID-19 testing reflects on glass at a bus stop, as pedestrians walk past Pfizer world headquarters in New York. BioNTech has at times been portrayed as the junior partner to U.S. pharmaceutical giant Pfizer in the race to get approval for their COVID vaccine, but the company's gene technology was key to the rapid development of the vaccine that British regulators have approved for emergency use Wednesday Dec. 2, 2020. (AP Photo/Bebeto Matthews, FILE)A truck leaves Pfizer Manufacturing in Puurs, Belgium, on Wednesday, Dec. 2, 2020. British officials authorized a COVID-19 vaccine for emergency use on Wednesday, greenlighting the world's first shot against the virus that's backed by rigorous science and taking a major step toward eventually ending the pandemic. (AP Photo/Virginia Mayo)This handout photo taken in Oct. 2020 and provided by Pfizer shows part of a "freezer farm," a football field-sized facility for storing finished COVID-19 vaccines, in Puurs, Belgium. Pfizer and BioNTech say they've won permission Wednesday, Dec. 2, 2020, for emergency use of their COVID-19 vaccine in Britain, the worlds first coronavirus shot thats backed by rigorous science -- and a major step toward eventually ending the pandemic. (Pfizer via AP)
Copyright 2020 The Associated Press. All rights reserved
File -- In this Tuesday, Nov.10, 2020 file photo windows are illuminated at the headquarters of the German biotechnology company BioNTech in Mainz, Germany. Pfizer and BioNTech say they've won permission Wednesday, Dec. 2, 2020, for emergency use of their COVID-19 vaccine in Britain, the world's first coronavirus shot that's backed by rigorous science -- and a major step toward eventually ending the pandemic.(AP Photo/Michael Probst, file)